Opus GeneticsIRD
那斯達克 · USD
3.98
-0.08
(-1.97%)
收盤 11/14 04:59 (UTC+8)
11/14 04:59 (UTC+8)
Opus GeneticsIRD
3.98
-0.08
(-1.97%)
財務數據
損益表
- 0.01
- 0.04
- 0.04
- 0.04
- 0.03
- 0.03
- 0.04
- 0.02
- 0.01
- 0.01
- -35.01
- 247.75
- 11.25
- 1.58
- -34.05
- 6.84
- 25.53
- -44.19
- -65.00
- 50.60
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | |
營業收入淨額 | 1,137 | 755 | 2,157 | 3,865 | 3,079 | 2,882 | 4,370 | 4,302 | 3,867 | 1,112 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,137 | 755 | 2,157 | 3,865 | 3,079 | 2,882 | 4,370 | 4,302 | 3,867 | 1,112 |
營業費用 | 20,384 | 17,235 | 16,521 | 15,318 | 11,390 | 11,788 | 14,299 | - | - | 9,440 |
研發費用 | 14,494 | 11,207 | 10,577 | 10,428 | 6,409 | 6,022 | 7,953 | 7,034 | 8,982 | 6,086 |
推銷及管理費用 | 5,890 | 6,028 | 5,944 | 4,890 | 4,981 | 5,766 | 6,346 | 7,297 | 2,894 | 3,354 |
非經常性項目費用 | - | - | - | - | - | - | - | 28,000 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,247 | -16,480 | -14,364 | -11,453 | -8,311 | -8,906 | -9,929 | -38,029 | -8,009 | -8,328 |
其他收入及費用 | -27,248 | 8,844 | -50,520 | -6,278 | -9,075 | 1,451 | 3,107 | 2,894 | 483 | 563 |
利息費用 | - | 462 | 651 | -1,208 | 68 | -35 | 1,372 | - | - | - |
稅前純益 | -46,495 | -8,098 | -65,535 | -16,523 | -17,454 | -7,420 | -8,194 | -35,135 | -7,526 | -7,765 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -46,495 | -8,098 | -65,535 | -16,523 | -17,454 | -7,420 | -8,194 | -35,135 | -7,526 | -7,765 |
基本每股稅後盈餘(元) | -0.46 | -0.08 | -0.75 | -0.19 | -0.25 | -0.12 | -0.24 | -1.27 | -0.29 | -0.30 |
稀釋每股稅後盈餘(元) | -0.46 | -0.06 | -0.75 | -0.21 | -0.27 | -0.08 | -0.24 | -1.27 | -0.29 | -0.30 |
基本平均股數(千股) | 101841.00 | 95483.00 | 86891.00 | 80991.00 | 70636.00 | 63376.00 | 33884.00 | 30370.00 | 26145.00 | 25827.00 |
稀釋平均股數(千股) | 101841.00 | 111384.00 | 86891.00 | 80991.00 | 70636.00 | 63376.00 | 33884.00 | 30370.00 | 26145.00 | 25827.00 |
還原基本每股稅後盈餘(元) | -0.46 | -0.08 | -0.75 | -0.19 | -0.25 | -0.12 | -0.24 | -1.27 | -0.29 | -0.30 |
還原稀釋每股稅後盈餘(元) | -0.46 | -0.06 | -0.75 | -0.21 | -0.27 | -0.08 | -0.24 | -1.27 | -0.29 | -0.30 |
還原基本平均股數(千股) | 101,841 | 95,483 | 86,891 | 80,991 | 70,636 | 63,376 | 33,884 | 30,370 | 26,145 | 25,827 |
還原稀釋平均股數(千股) | 101,841 | 111,384 | 86,891 | 80,991 | 70,636 | 63,376 | 33,884 | 30,370 | 26,145 | 25,827 |
EBITDA(千元) | -46,473 | -7,622 | -64,871 | -17,718 | -17,373 | -7,441 | -6,809 | -35,125 | -7,526 | -7,765 |